More articles from Controversy

You have access
The 2003 Canadian recommendations for dyslipidemia management: Revisions are needed
Douglas G. Manuel, Peter Tanuseputro, Cameron A. Mustard, Susan E. Schultz, Geoffrey M. Anderson, Sten Ardal, David A. Alter and Andreas Laupacis

CMAJ April 12, 2005 172 (8) 1027-1031; DOI: https://doi.org/10.1503/cmaj.1040202
You have access
Rebuttal
Douglas G. Manuel, Peter Tanuseputro, Cameron A. Mustard, Susan E. Schultz, Geoffrey M. Anderson, Sten Ardal, David A. Alter and Andreas Laupacis

CMAJ April 12, 2005 172 (8) 1037; DOI: https://doi.org/10.1503/cmaj.1041748
You have access
The analysis by Manuel and colleagues creates controversy with headlines, not data
Jacques Genest, Ruth McPherson, Jiri Frohlich and George Fodor

CMAJ April 12, 2005 172 (8) 1033-1034; DOI: https://doi.org/10.1503/cmaj.1041427
You have access
Rebuttal
CMAJ January 09, 2001 164 (1) 40;
You have access
Mass influenza vaccination in Ontario: Is it worthwhile?
Vittorio Demicheli

CMAJ January 09, 2001 164 (1) 38-39;
You have access
Mass influenza vaccination in Ontario: a sensible move
Richard E. Schabas

CMAJ January 09, 2001 164 (1) 36-37;
You have access
Rebuttal
CMAJ January 09, 2001 164 (1) 41;
You have access
Why Sackett‚s analysis of randomized controlled trials fails, but needn‚t
Stanley H. Shapiro and Kathleen Cranley Glass

CMAJ October 03, 2000 163 (7) 834-835;
You have access
Equipoise, a term whose time (if it ever came) has surely gone
David L. Sackett

CMAJ October 03, 2000 163 (7) 835-836;
You have access
Rebuttal
Sidney J. Winawer and Ann Zauber

CMAJ September 05, 2000 163 (5) 547;

Main menu

User menu

Search

More articles from Controversy

Pages

Content

Information for

About